Get started
Author

Danielle Sookiasian

Observed name: D. Sookiasian
ORCID: 0009-0000-5534-6066
Observed ORCID: 0009-0000-5534-6066
OpenAlex ID: A5037424291
Molecular characterization of precise in vivo targeted gene integration in human cells using AAVHSC15
2020 · Huei-Mei Chen, Rachel Resendes, et al. · PLoS ONE · 12
PDF
Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2024 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al. · Clinical Cancer Research · 11
PDF
Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort
2025 · Anastasiya Yudina, Cagdas Tazearslan, et al. · Communications Medicine · 5
PDF
A Novel Comprehensive Tumor-Informed Plasma cfDNA Assay to Monitor Minimal Residual Disease for Hematological and Solid Malignancies
2023 · Anastasiya Yudina, Anastasiya Danchurova, et al. · Blood · 1
Molecular Findings on Plasma Cell-Free DNA Analysis Among Adults with Histiocytic Neoplasms
2023 · Gaurav Goyal, Aldo Adrian Acosta Medina, et al. · Blood · 1
Genome-wide assays to characterize rAAV integration into human genomic DNA in vivo
2023 · Jaime Prout, Jessica Von Stetina, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 1042: Analytical validation of a liquid biopsy test using cell-free circulating tumor DNA for mutational profiling
2023 · Anastasiya Yudina, Alexey Efremov, et al. · Cancer Research · 1
Abstract 1067: Whole genome sequencing of multiple myeloma genomes with a novel clinical assay enables identification of genetic alterations underlying immunotherapy resistance
2026 · Bruno Paiva, Peter Voorhees, et al. · Cancer Research
Comprehensive characterization of multiple myeloma genomes from bone marrow or peripheral blood with a novel clinical assay enables identification of resistance mechanisms
2025 · Bruno Paiva, Patricia Greipp, et al. · Blood
PDF
Supplementary Figure S3 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Table S2 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Table S4 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Figure S2 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
PDF
Supplementary Appendix S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Table S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Figure S4 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Figure S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
PDF
Supplementary Table S3 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Comprehensive Characterization of Myeloma Genomes from Bone Marrow and Peripheral Blood Using a Novel Clinical Assay
2025 · Bruno Paiva, Patricia Greipp, et al. · Clinical Lymphoma Myeloma & Leukemia
Supplementary Table S3 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Appendix S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Figure S1 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Data from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Table S2 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Supplementary Figure S4 from Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma
2025 · Eric V. Mastrolonardo, Kathryn L. Nunes, et al.
Works count: 30
Citation count: 32
H-index: 3
I10-index: 2
Year
Topic
Type